HomeComparePCIMF vs MRK

PCIMF vs MRK: Dividend Comparison 2026

PCIMF yields 14285.71% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PCIMF wins by $1868328188208921344.00M in total portfolio value
10 years
PCIMF
PCIMF
● Live price
14285.71%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1868328188208921344.00M
Annual income
$1,842,950,648,126,759,800,000,000.00
Full PCIMF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — PCIMF vs MRK

📍 PCIMF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPCIMFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PCIMF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PCIMF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PCIMF
Annual income on $10K today (after 15% tax)
$1,214,285.71/yr
After 10yr DRIP, annual income (after tax)
$1,566,508,050,907,746,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, PCIMF beats the other by $1,566,508,050,907,746,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PCIMF + MRK for your $10,000?

PCIMF: 50%MRK: 50%
100% MRK50/50100% PCIMF
Portfolio after 10yr
$934164094104460672.00M
Annual income
$921,475,324,063,379,900,000,000.00/yr
Blended yield
98.64%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

PCIMF
No analyst data
Altman Z
-523.9
Piotroski
0/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PCIMF buys
0
MRK buys
0
No recent congressional trades found for PCIMF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPCIMFMRK
Forward yield14285.71%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$1868328188208921344.00M$56.8K
Annual income after 10y$1,842,950,648,126,759,800,000,000.00$9,798.13
Total dividends collected$1866648039868218112.00M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: PCIMF vs MRK ($10,000, DRIP)

YearPCIMF PortfolioPCIMF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$1,439,271$1,428,571.43$11,206$366.19+$1.43MPCIMF
2$193,699,090$192,159,069.24$12,650$502.35+$193.69MPCIMF
3$24,376,441,818$24,169,183,791.94$14,407$694.19+$24376.43MPCIMF
4$2,868,716,750,186$2,842,633,957,441.24$16,585$967.82+$2868716.73MPCIMF
5$315,716,708,842,374$312,647,181,919,674.60$19,342$1,363.89+$315716708.82MPCIMF
6$32,495,195,455,130,188$32,157,378,576,668,850.00$22,913$1,947.19+$32495195455.11MPCIMF
7$3,128,044,259,554,657,300$3,093,274,400,417,667,600.00$27,662$2,823.89+$3128044259554.63MPCIMF
8$281,631,115,249,329,080,000$278,284,107,891,605,600,000.00$34,159$4,173.35+$281631115249329.06MPCIMF
9$23,717,327,179,590,366,000,000$23,415,981,886,273,583,000,000.00$43,337$6,308.80+$23717327179590368.00MPCIMF
10$1,868,328,188,208,921,400,000,000$1,842,950,648,126,759,800,000,000.00$56,776$9,798.13+$1868328188208921344.00MPCIMF

PCIMF vs MRK: Complete Analysis 2026

PCIMFStock

Pacific Imperial Mines Inc. engages in the identification, evaluation, acquisition, exploration, and development of mineral properties. It primarily explores for gold and base metal properties. The company holds a 100% interest in the Eagle Mountain lithium prospect comprises 125 placer claim units totaling approximately 2500 acres located in Inyo County, California. It also has an option to acquire 100% in the TREK 31 Property, consisting of five claims that covers an area of 94 square kilometers located in the Nechako Plateau of central British Columbia; and the Tulameen-Granite Creek Property comprising four claims totaling 2808 hectares located in southern British Columbia. Pacific Imperial Mines Inc. was incorporated in 1987 and is based in Vancouver, Canada.

Full PCIMF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this PCIMF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PCIMF vs SCHDPCIMF vs JEPIPCIMF vs OPCIMF vs KOPCIMF vs MAINPCIMF vs JNJPCIMF vs ABBVPCIMF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.